Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Wechsler

Showing results (111-120 of 213) with videos related to

Pageof 22
Sort By:
AJNR. American Journal of Neuroradiology|March 1, 1994
CT after intracranial intraarterial thrombolysis for acute strokeS L Wildenhain, C A Jungreis, J Barr, et al.
Virus Research|November 1, 1985
Human parainfluenza virus 3: purification and characterization of subviral components, viral proteins and viral RNAS L Wechsler, D M Lambert, M S Galinski, et al.
Current Eye Research|October 30, 2004
Glycoprotein C of herpes simplex virus type 1 is required to cause keratitis at low infectious doses in intact rabbit corneasBarbra S Drolet, Kevin R Mott, Andrew M Lippa, et al.
Journal of Virology|August 1, 1994
Vaccine therapy for ocular herpes simplex virus (HSV) infection: periocular vaccination reduces spontaneous ocular HSV type 1 shedding in latently infected rabbitsA B Nesburn, R L Burke, H Ghiasi, et al.
Journal of Neurovirology|June 14, 2015
The herpes simplex virus type 1 (HSV-1) latency-associated transcript (LAT) protects cells against cold-shock-induced apoptosis by maintaining phosphorylation of protein kinase B (AKT)Dale Carpenter, Chinhui Hsiang, Xianzhi Jiang, et al.
Virology|November 1, 1986
Molecular cloning and sequence analysis of the human parainfluenza 3 virus mRNA encoding the P and C proteinsM S Galinski, M A Mink, D M Lambert, et al.
Immunology|July 1, 1997
The importance of MHC-I and MHC-II responses in vaccine efficacy against lethal herpes simplex virus type 1 challengeH Ghiasi, D C Roopenian, S Slanina, et al.
Journal of Virology|October 9, 1999
Herpes simplex virus type 1 serum neutralizing antibody titers increase during latency in rabbits latently infected with latency-associated transcript (LAT)-positive but not LAT-negative virusesG C Perng, S M Slanina, A Yukht, et al.
The Journal of Infectious Diseases|April 7, 1999
The role of interleukin (IL)-2 and IL-4 in herpes simplex virus type 1 ocular replication and eye diseaseH Ghiasi, S Cai, S M Slanina, et al.
Vaccine|July 27, 1999
Vaccination with different HSV-1 glycoproteins induces different patterns of ocular cytokine responses following HSV-1 challenge of vaccinated miceH Ghiasi, F M Hofman, S Cai, et al.
Pageof 22

Showing results (111-120 of 213) with videos related to

Sort By:
Pageof 22
AJNR. American Journal of Neuroradiology|March 1, 1994
CT after intracranial intraarterial thrombolysis for acute strokeS L Wildenhain, C A Jungreis, J Barr, et al.
Virus Research|November 1, 1985
Human parainfluenza virus 3: purification and characterization of subviral components, viral proteins and viral RNAS L Wechsler, D M Lambert, M S Galinski, et al.
Current Eye Research|October 30, 2004
Glycoprotein C of herpes simplex virus type 1 is required to cause keratitis at low infectious doses in intact rabbit corneasBarbra S Drolet, Kevin R Mott, Andrew M Lippa, et al.
Journal of Virology|August 1, 1994
Vaccine therapy for ocular herpes simplex virus (HSV) infection: periocular vaccination reduces spontaneous ocular HSV type 1 shedding in latently infected rabbitsA B Nesburn, R L Burke, H Ghiasi, et al.
Journal of Neurovirology|June 14, 2015
The herpes simplex virus type 1 (HSV-1) latency-associated transcript (LAT) protects cells against cold-shock-induced apoptosis by maintaining phosphorylation of protein kinase B (AKT)Dale Carpenter, Chinhui Hsiang, Xianzhi Jiang, et al.
Virology|November 1, 1986
Molecular cloning and sequence analysis of the human parainfluenza 3 virus mRNA encoding the P and C proteinsM S Galinski, M A Mink, D M Lambert, et al.
Immunology|July 1, 1997
The importance of MHC-I and MHC-II responses in vaccine efficacy against lethal herpes simplex virus type 1 challengeH Ghiasi, D C Roopenian, S Slanina, et al.
Journal of Virology|October 9, 1999
Herpes simplex virus type 1 serum neutralizing antibody titers increase during latency in rabbits latently infected with latency-associated transcript (LAT)-positive but not LAT-negative virusesG C Perng, S M Slanina, A Yukht, et al.
The Journal of Infectious Diseases|April 7, 1999
The role of interleukin (IL)-2 and IL-4 in herpes simplex virus type 1 ocular replication and eye diseaseH Ghiasi, S Cai, S M Slanina, et al.
Vaccine|July 27, 1999
Vaccination with different HSV-1 glycoproteins induces different patterns of ocular cytokine responses following HSV-1 challenge of vaccinated miceH Ghiasi, F M Hofman, S Cai, et al.
Pageof 22